Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy

Ann Oncol. 2017 Jul 1;28(7):1658-1666. doi: 10.1093/annonc/mdx170.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / pharmacology*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • B7-H1 Antigen / antagonists & inhibitors*
  • B7-H1 Antigen / immunology
  • Clinical Trials, Phase I as Topic
  • Dose-Response Relationship, Drug
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / immunology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • B7-H1 Antigen
  • CD274 protein, human
  • avelumab